We basically said if these companies are selling things like insulin and they are jacking up the prices again and again and again, which they have, they basically have to make rebates if they ever raise prices above inflation.
Wyden discusses a bipartisan bill to combat pharmaceutical price gouging.
Share
More from Ron Wyden
Flock’s AI surveillance cameras have sparked a nationwide backlash against unnecessary government intrusion into Americans’ lives.
This is another desperate attempt by a failed president to escape Americans’ revulsion with his failed agenda, amounting to one tank of Trump-inflated gas.
This throws doubt upon Treasury’s interpretation of many provisions of the Code, creates a great deal of uncertainty in the administration of our tax laws, and could balloon the deficit.
This interpretation is wildly inconsistent with the longstanding treatment of other provisions that use identical or near-identical language.
Other voices in this conversation
